Edition:
United States

Vivus Inc (VVUS.OQ)

VVUS.OQ on NASDAQ Stock Exchange Global Select Market

3.34USD
3:59pm EST
Change (% chg)

$0.15 (+4.70%)
Prev Close
$3.19
Open
$3.20
Day's High
$3.44
Day's Low
$3.18
Volume
11,414
Avg. Vol
14,739
52-wk High
$9.88
52-wk Low
$3.18

Chart for

About

VIVUS, Inc. is a biopharmaceutical company. The Company operates in the development and commercialization of therapeutic products segment. It provides over two therapies approved by the Food and Drug Association (FDA), which include Qsymia (phentermine and topiramate extended-release) for chronic weight management and STENDRA... (more)

Overall

Beta: 0.70
Market Cap(Mil.): $35.40
Shares Outstanding(Mil.): 10.63
Dividend: --
Yield (%): --

Financials

  VVUS.OQ Industry Sector
P/E (TTM): -- 28.14 29.53
EPS (TTM): -3.98 -- --
ROI: -16.91 13.50 13.00
ROE: -- 15.26 14.69

BRIEF-Vivus Says Got Letter From Nasdaq Informing that it Granted Co's Request For Continued Listing, On Conditions

* VIVUS SAYS ON MAY 17, GOT LETTER FROM NASDAQ INFORMING NASDAQ HEARINGS PANEL GRANTED CO'S REQUEST FOR CONTINUED LISTING, ON CONDITIONS- SEC FILING Source text: (https://bit.ly/2KyiHGO) Further company coverage: (Reuters.Briefs@thomsonreuters.com)

May 18 2018

Earnings vs. Estimates